Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Client redemptions and headwinds keep conditions challenging for Gottex

Wednesday, December 12, 2012

Beverly Chandler, Opalesque London: Gottex Fund Management reports that it continues to face headwinds in its fund of fund business 'as a substantial number of large institutional investors develop their own capabilities’.

"Although we have successfully been awarded mandates in excess of $125m in the fourth quarter, one of our investors will terminate a $525m relative value and event driven segregated managed account as of January 2013" the firm writes. "Other client redemptions are within the company’s historical range".

The firm says that strategic growth initiatives for 2013, include growing their multi asset products and capabilities in Europe and Asia. "We will further develop our growing Asian business as the gateway between non-APAC based investors seeking to access Asian investment opportunities by leveraging our deep knowledge of Asian markets and investments, while offering outbound services to APAC based investors seeking global diversification in their portfolios" the firm said. For the LUMA managed account platform, Gottex will seek to form partnerships with asset owners to provide specific platform solutions and bring further scale to the business.

Gottex’s flagship market neutral product and related separately managed accounts are all above their high water marks and accruing incentive fees, the firm reports, while three of their hedge fund products have returned over 10% year to date.......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its